Tuesday, August 30, 2016

BRIEF-Karyopharm Therapeutics provides update on Phase 2b STORM study

* Intends to expand its Phase 2b storm study evaluating

activity of selinexor in multiple myeloma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)